Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-25 @ 4:15 AM
NCT ID:
NCT00815620
Eligibility Criteria:
Inclusion Criteria:
* Biopsy-proven neuroendocrine tumor (WHO class I-II, TNM grading 1-2)
* Advanced disease with lymph node or distant metastases (N1, M1) undergoing cytoreduction by surgery/local ablative therapy or peptide receptor radiotherapy
* curative intent of all therapies possible
Exclusion Criteria:
* Undifferentiated neuroendocrine carcinoma (WHO class III, TNM grading 3)
* secondary tumor
* advanced carcinoid heart disease requiring surgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT00815620
Study Brief:
Protocol Section:
NCT00815620